{
  "ticker": "ATRA",
  "date": "2026-01-07",
  "archetype": "unknown",
  "industry": "biotech",
  "result": "PASS",
  "reason": "Kill screens failed",
  "kill_screens": {
    "m_score": {
      "value": 27.53,
      "threshold": -1.78,
      "pass": false,
      "note": "Extreme anomaly - far outside expected range of -2 to +2"
    },
    "z_score": {
      "value": -84.55,
      "threshold": 1.5,
      "industry_adjusted": true,
      "pass": false,
      "note": "Extreme anomaly - far outside expected range of -5 to +10"
    }
  },
  "market_data": {
    "price": 14.80,
    "price_source": "Stooq (15-min delay)",
    "market_cap": 106708000,
    "shares_outstanding": 7210000
  },
  "financials": {
    "total_assets": 30167000,
    "total_liabilities": 66801000,
    "working_capital": 375000,
    "revenue": 119177000,
    "ebit": 38425000,
    "net_income": 36094000,
    "equity": -36634000,
    "note": "Negative equity - liabilities exceed assets by $36.6M"
  },
  "data_sources": [
    "Stooq (15-min delay)",
    "SEC XBRL API"
  ],
  "data_quality_warnings": [
    "M-Score 27.53 far outside expected range (-2 to +2)",
    "Z-Score -84.55 far outside expected range (-5 to +10)",
    "Negative book value - liabilities exceed assets"
  ],
  "analysis_notes": "Company has severe financial distress with negative equity. Both M-Score and Z-Score show catastrophic levels indicating high manipulation risk and bankruptcy risk. Automatic PASS per framework rules."
}
